Sponsor pipeline

The University of Texas Health Science Center at San Antonio clinical trial pipeline

Get alerts when The University of Texas Health Science Center at San Antonio's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

10 trials changed in the last 30 days: 0 stopped, 6 with notable changes, 4 with minor changes only.

  1. Notable

    MemoryRT · Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the Brain

    Recruitment opened

    Also in this update: Primary completion pushed from Mar 2030 to Jul 2030; Study completion pushed from Mar 2031 to Jul 2031

    The University of Texas Health Science Center at San AntonioPhase 2 NCT07470606 Registry history of NCT07470606 on ClinicalTrials.gov (opens the registry)

    Updated

Show 4 trials with minor changes only
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-10-09 NCT07868913 Alleviating Suicidality by Combining Psychotherapy and IM Ketamine for Rapid Treatment in… Phase 2 Recruiting
2026-09-29 NCT07845825 Aprepitant for the Treatment of CLIFAHDD Early Phase 1 Recruiting
2026-09-23 NCT07836725 Radiographic Changes in the Maxillary Sinus Following Closed Sinus Augmentation With… Early Phase 1 Not Yet Recruiting
2026-09-21 NCT07832110 The Effect of Dexamethasone on Short Term Patient Response: IV vs Oral Administration Phase 1/2 Not Yet Recruiting

Active trials by phase

Early Phase 1
14
Phase 1
7
Phase 1/2
2
Phase 2
11
Phase 2/3
1
Phase 3
2
Phase 4
5
Not charted: 56 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials top 25 of 98

NCT IDTitleConditionStatusUpdated
Phase 4
NCT03765567 Placement of Antibiotic Powder in Wounds During the Emergency Room Open Fracture Recruiting 2026-09-30
NCT05838287 Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants Type 2 Diabetes Mellitus in Obese Recruiting 2026-09-22
NCT05305287 Quantifying Hepatic Mitochondrial Fluxes in Humans Non-Alcoholic Fatty Liver Disease Recruiting 2026-08-17
NCT05590637 Comparing Antipsychotic Medications in LBD Over Time Parkinson's Disease Psychosis Recruiting 2025-09-09
NCT03878459 Dapagliflozin Plus Pioglitazone in T1DM Type 1 Diabetes Mellitus Active, Not Recruiting 2026-07-29
Phase 3
NCT07056699 SGLT2i, Pioglitazone, and Ketone Production in T1D Type1diabetes Recruiting 2026-07-20
NCT06246799 Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent… Type 2 Diabetes (Adult Onset) Recruiting 2026-03-10
Phase 2/3
NCT05696691 Ketamine & Crisis Response Plan for Suicidal Ideation in the ED Suicide Recruiting 2026-09-30
Phase 2
NCT07868913 Alleviating Suicidality by Combining Psychotherapy and IM Ketamine for Rapid Treatment in… Suicidal Ideation Recruiting 2026-10-15
NCT07470606 Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the Brain Brain Tumor Recruiting 2026-09-22
NCT06811324 Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults Obesity Prevention Recruiting 2026-04-15
NCT04559230 Sacituzumab Govitecan in Recurrent Glioblastoma Recurrent Glioblastoma Recruiting 2026-03-30
NCT06526104 Study of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular… Hepatocellular Carcinoma Recruiting 2026-01-06
NCT05889741 Combining Stellate Ganglion Block With Prolonged Exposure for PTSD Stress Disorders, Post-Traumatic Recruiting 2025-09-04
NCT04863950 Investigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent… Glioblastoma Recruiting 2025-08-27
NCT04742777 Effect of mTOR Inhibition & Other Metabolism Modulating Interventions on the Elderly… Aging Active, Not Recruiting 2026-09-23
NCT05720325 Dupilumab Effects Against Aeroallergen Challenge Asthma, Allergic Active, Not Recruiting 2026-08-11
NCT04629495 Rapamycin - Effects on Alzheimer's and Cognitive Health Mild Cognitive Impairment Active, Not Recruiting 2026-06-09
NCT04081220 Hematology, IMG-7289, LSD1 (Lysine-Specific Demethylase 1) Inhibitor, Essential… Thrombocythemia, Essential Active, Not Recruiting 2025-09-10
Phase 1/2
NCT07832110 The Effect of Dexamethasone on Short Term Patient Response: IV vs Oral Administration Post Operative Pain, Acute Not Yet Recruiting 2026-09-21
NCT06609343 Bupropion for Fatigue in End-stage Kidney Disease Patients on Hemodialysis End Stage Renal Disease Not Yet Recruiting 2026-08-11
Phase 1
NCT07212868 The Role of Glucagon in Glucose Metabolism in Humans With and Without Bariatric Surgery Non-Diabetic Recruiting 2026-10-05
NCT06977711 Loncastuximab and Roflumilast Added to R-CHOP (Lo-(Rituximab and Roflumilast) RR-CHOP)… Diffuse Large B-cell Lymphoma Recruiting 2026-09-29
NCT05960656 SGLTi, Hepatic Glucose Production and Ketogenesis Type 2 Diabetes Recruiting 2026-07-17
NCT07053306 SGLT2i, Ketoacidosis, Volume Contraction, and Insulinopenia Type 2 Diabetes Recruiting 2026-07-17

Disease areas by active trials, top 10 of 28

Get alerts when The University of Texas Health Science Center at San Antonio's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free